Supplyside West
Biofarma Group to Showcase Latest Nutraceutical Innovations
The company will represent the newly-acquired US Pharma Lab and showcase delivery technologies for liquid and powder formats.
By: Mike Montemarano
Booth 7850
Biofarma Group, a global contract development and manufacturing organization (CDMO), will be exhibiting its capabilities at SupplySide West.
The company, which specializes in supplements, medical devices, probiotic-based drugs, and cosmetics, recently acquired US Pharma Lab, enabling it to emerge in the nutraceutical industry.
Biofarma Group will be highlighting its capabilities in the dietary supplement, food, beverage, pet health, and personal care industries. For the second year running, it will be represented by US Pharma Lab, where experts will discuss its capabilities across eight plants which geographically cross the continents of Europe, America, and Asia.
The stand will showcase a full portfolio of technologies ranging from solid and semi-solid to liquid and powder forms, including single- and multi-layer tablets, capsules, minitabs, beadlets, ready-to-drink powders, chewables, and orally-dissolving tablets.
